Get the Stockscreener App
43.71
0.19%
-0.09
After Hours:
44.00
0.29
+0.66%
Doximity Inc stock is traded at $43.71, with a volume of 2.24M.
It is down -0.19% in the last 24 hours and down -7.13% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
See More
Previous Close:
$43.80
Open:
$44
24h Volume:
2.24M
Relative Volume:
1.13
Market Cap:
$8.23B
Revenue:
$550.17M
Net Income/Loss:
$201.35M
P/E Ratio:
43.71
EPS:
1
Net Cash Flow:
$232.07M
1W Performance:
-2.94%
1M Performance:
-7.13%
6M Performance:
-25.29%
1Y Performance:
-17.05%
1-Day Range:
$43.50
$44.52
1-Week Range:
$43.50
$46.65
52-Week Range:
$43.50
$85.21
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
43.71 | 8.25B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
215.30 | 36.05B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
64.61 | 12.12B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
95.31 | 8.20B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
35.59 | 6.57B | 11.99B | 24.18M | 234.31M | 0.2956 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-21-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-27-25 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-10-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-25 | Downgrade | Goldman | Neutral → Sell |
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Piper Sandler sees Doximity and Phreesia as oversold, recommends buying By Investing.com - Investing.com South Africa
BofA Securities maintains Buy rating on Doximity stock amid pharma ad trends By Investing.com - Investing.com South Africa
Doximity stock hits 52-week low at 43.59 USD - Investing.com India
Piper Sandler sees Doximity and Phreesia as oversold, recommends buying - Investing.com India
Piper Sandler recommends buying Doximity and Phreesia stock after pharma marketing event - Investing.com Nigeria
BofA Securities maintains Buy rating on Doximity stock amid pharma ad trends - Investing.com India
Texas Permanent School Fund Corp Acquires 82,274 Shares of Doximity, Inc. $DOCS - MarketBeat
How Doximity is looking to break through AI skepticism - Modern Healthcare
Doximity (DOCS) ascends while market falls: Some facts to note - MSN
Doximity (DOCS) Ascends While Market Falls: Some Facts to Note - sharewise.com
Doximity (DOCS): Taking Stock of Valuation After Analyst Upgrades on AI Tools and Growth Outlook - Yahoo Finance UK
Doximity Sees Surge as AI Tools and Analyst Ratings Impress - StocksToTrade
Is Doximity Now an Opportunity After Recent Share Price Slide? - Yahoo Finance
Doximity rises after Morgan Stanley upgrades to 'overweight' - TradingView — Track All Markets
Doximity upgraded at Morgan Stanley on expanding market for HCP platforms - MSN
Doximity (NASDAQ:DOCS) Shares Gap UpStill a Buy? - MarketBeat
Doximity Offers Attractive Entry Point, Morgan Stanley Says - marketscreener.com
Doximity’s underperformance at odds with improving business, says MS - Investing.com
Morgan Stanley Upgrades Doximity to Overweight From Equalweight, Raises Price Target to $65 From $62 - marketscreener.com
Morgan Stanley upgrades Doximity stock to Overweight on conservative outlook - Investing.com Canada
Doximity (DOCS) Stock Trends and Sentiment 2025 - MarketBeat
Doximity, Inc. (NYSE:DOCS) Q2 2026 Earnings Call Transcript - MSN
Liontrust Investment Partners LLP Increases Stock Holdings in Doximity, Inc. $DOCS - MarketBeat
AI Stocks: Will Doximity Inc stock keep outperforming rivals2025 Risk Factors & High Conviction Buy Zone Picks - moha.gov.vn
Published on: 2025-12-13 18:23:14 - moha.gov.vn
Healthcare AI Exits Pilot Phase, Enters Production Deployment - AI Magazine
Doximity director Yang Watkin Phoebe L. sells $217,209 in stock - MSN
Doximity (NASDAQ:DOCS) Reaches New 52-Week LowWhat's Next? - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Hims & Hers Expands Its Technology-Driven Personalized Virtual Care - The Globe and Mail
Federated Hermes Inc. Has $11.47 Million Stock Holdings in Doximity, Inc. $DOCS - MarketBeat
Baird Financial Group Inc. Invests $4.14 Million in Doximity, Inc. $DOCS - MarketBeat
Doximity: Inside the Multimodal Surge — How a 5% Feature Became 40% of Bookings in One Year! - Smartkarma
Barclays Initiates Coverage on Doximity (NASDAQ:DOCS) - MarketBeat
Natixis Grows Position in Doximity, Inc. $DOCS - MarketBeat
Invesco Ltd. Has $116.20 Million Stock Position in Doximity, Inc. $DOCS - MarketBeat
Norges Bank Invests $6.21 Million in Doximity, Inc. $DOCS - MarketBeat
Prudential Financial Inc. Has $680,000 Stock Position in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. $DOCS Holdings Cut by First Trust Advisors LP - MarketBeat
Is Doximity’s (DOCS) AI Surge Turning Workflow Tools Into Its Core Investment Story? - Sahm
Doximity (DOCS) Gains Overweight Rating from Barclays | DOCS Sto - GuruFocus
Rep. Jonathan L. Jackson Sells Doximity, Inc. (NASDAQ:DOCS) Shares - MarketBeat
Here's Why We Think Doximity (NYSE:DOCS) Is Well Worth Watching - Yahoo Finance
Illinois Rep. Jonathan Jackson Sold Up to $80K Worth of Doximity Stock - Benzinga
Doximity: Strong Quarter Overshadowed By Policy-Driven Budget Uncertainty (NYSE:DOCS) - Seeking Alpha
Doximity stock holds steady as Wells Fargo maintains Equal Weight rating By Investing.com - Investing.com South Africa
Doximity stock holds steady as Wells Fargo maintains Equal Weight rating - Investing.com Canada
New York State Common Retirement Fund Reduces Stock Position in Doximity, Inc. $DOCS - MarketBeat
Doximity: Elite Margins, AI Growth, And An Attractive Multiple (NYSE:DOCS) - Seeking Alpha
Doximity (NASDAQ:DOCS) Trading Down 10.5%Here's What Happened - MarketBeat
InvestingPro’s Fair Value model predicted Doximity’s 41% stock decline By Investing.com - Investing.com
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):